3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
16
Observational
1
Expanded_access
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Myelodysplastic Syndromes
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hematologic Neoplasms
1
Anemia, Sickle Cell
1
Anemia, Aplastic
1
Interventions
Psychiatric Rehabilitation
7
Flow Cytometry
6
Therapeutics
5
Surveys and Questionnaires
5
Microarray Analysis
5
Gene Expression Profiling
5
Vincristine
4
Polymerase Chain Reaction
4
Methotrexate
4
Daunorubicin
4
Cytogenetic Analysis
4
Amplified Fragment Length Polymorphism Analysis
4
ponatinib
3
fludarabine
3
Watchful Waiting
3
Prednisone
3
Observation
3
Mercaptopurine
3
Interviews as Topic
3
Inotuzumab Ozogamicin
3
Immunologic Techniques
3
Immunoenzyme Techniques
3
Cytarabine
3
Cyclophosphamide
3
tisagenlecleucel
2
pegaspargase
2
fish oil triglycerides
2
blinatumomab
2
In Situ Hybridization, Fluorescence
2
Imatinib Mesylate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Bone Marrow Transplantation
×
Clear all
NCT07145411
2025-08-28
HOPE
Ossium Health, Inc.
Recruiting
10 enrolled